{
    "clinical_study": {
        "@rank": "36974", 
        "acronym": "AQUIRe", 
        "arm_group": [
            {
                "arm_group_label": "Neuromuscular Disease Patients", 
                "description": "Amyotrophic lateral sclerosis patients, myopathy patients, muscular dystrophy patients, myasthenia gravis patients, radiculopathy patients, mononeuropathy patients"
            }, 
            {
                "arm_group_label": "Healthy volunteers"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is utilizing ultrasound measurement to measure neuromuscular disease status in\n      adult patients. The hypothesis is the by quantifying ultrasound data, it is possible that\n      ultrasound can be utilized as a tool to determine if a disease is responding to therapy or\n      progressing."
        }, 
        "brief_title": "Innovative Ultrasound Technology in Neuromuscular Disease", 
        "completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Amyotrophic Lateral Sclerosis", 
            "Muscular Dystrophy", 
            "Radiculopathy", 
            "Myopathy", 
            "Polyneuropathy and Mononeuropathies"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Amyotrophic Lateral Sclerosis", 
                "Muscular Diseases", 
                "Muscular Dystrophies", 
                "Neuromuscular Diseases", 
                "Sclerosis", 
                "Polyneuropathies", 
                "Motor Neuron Disease", 
                "Mononeuropathies", 
                "Radiculopathy"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  History of a well-defined, localized or generalized neuromuscular condition producing\n             weakness or muscle atrophy, including disuse atrophy.\n\n        Exclusion Criteria:\n\n          -  Multiple generalized neuromuscular conditions."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "21 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with any neuromuscular disorder (i.e. primary nerve or muscle disease), both\n        localized and generalized, producing some degree of weakness or disability."
            }
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02104921", 
            "org_study_id": "2K24NS060951"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 2, 2014", 
        "location": {
            "contact": {
                "email": "syim@bidmc.harvard.edu", 
                "last_name": "Sung Yim", 
                "phone": "617-667-3015"
            }, 
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02215"
                }, 
                "name": "Beth Israel Deaconess Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Seward B Rutkove, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Courtney McIlduff, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "overall_contact": {
            "email": "syim@bidmc.harvard.edu", 
            "last_name": "Sung Lim", 
            "phone": "617-667-3053"
        }, 
        "overall_contact_backup": {
            "email": "amijailo@bidmc.harvard.edu", 
            "last_name": "Alex Mijailovic", 
            "phone": "617-667-3053"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Ultrasound data will be collected on multiple muscles in each person. The images will then be quantified using either 1. A grayscale technique in which the images themselves are analyzed via standard image software (e.g., Adobe Photoshop) as to level of echo intensity in a pre-specific region of interest or 2. the raw quantified backscatter data is captured by the transducer, expressed as a unit of power, in the same pre-specified area of interest", 
            "measure": "Quantitative ultrasound data, including quantified grayscale data and backscattered acoustic data", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02104921"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Beth Israel Deaconess Medical Center", 
            "investigator_full_name": "Seward Rutkove", 
            "investigator_title": "Professor of Neurology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Beth Israel Deaconess Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institutes of Health (NIH)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Beth Israel Deaconess Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}